Literature DB >> 12122070

D1 dopamine receptor regulation of microtubule-associated protein-2 phosphorylation in developing cerebral cortical neurons.

Z-M Song1, A S Undie, P O Koh, Y-Y Fang, L Zhang, S Dracheva, S C Sealfon, M S Lidow.   

Abstract

This study addresses the hypothesis that the previously described capacity of D1 dopamine receptors (D1Rs) to regulate dendritic growth in developing cortical neurons may involve alterations in the phosphorylation state of microtubule-associated protein-2 (MAP2). The changes in phosphorylation of this protein are known to affect its ability to stabilize the dendritic cytoskeleton. The study involved two systems: primary cultures of mouse cortical neurons grown in the presence of the D1R agonists, SKF82958 or A77636, and the cortex of neonatal transgenic mice overexpressing the D1A subtype of D1R. In both models, a decrease in dendritic extension corresponded with an elevation in MAP2 phosphorylation. This phosphorylation occurred on all three amino acid residues examined in this study: serine, threonine, and tyrosine. In cultured cortical neurons, D1R stimulation-induced increase in MAP2 phosphorylation was blocked by the protein kinase A (PKA) inhibitor, H-89, and mimicked by the PKA activator, S(p)-cAMPS. This indicates that D1Rs modulate MAP2 phosphorylation through PKA-associated intracellular signaling pathways. We also observed that the elevations in MAP2 phosphorylation in neuronal cultures in the presence of D1R agonists (or S(p)-cAMPS) were maintained for a prolonged time (up to at least 96 hr). Moreover, MAP2 phosphorylation underwent a substantial increase between 24 and 72 hr of exposure to these drugs. Our findings are consistent with the idea that D1Rs can modulate growth and maintenance of dendrites in developing cortical cells by regulating the phosphorylation of MAP2. In addition, our observations suggest that MAP2 phosphorylation by long-term activation of D1Rs (and PKA) can be divided into two phases: the initial approximately 24-hr-long phase of a relatively weak elevation in phosphorylation and the delayed phase of a much more robust phosphorylation increase taking place during the next approximately 48 hr.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12122070      PMCID: PMC6757946          DOI: 20026478

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  18 in total

Review 1.  Neurobehavioral changes arising from early life dopamine signaling perturbations.

Authors:  Lorena B Areal; Randy D Blakely
Journal:  Neurochem Int       Date:  2020-04-20       Impact factor: 3.921

Review 2.  Drugs, biogenic amine targets and the developing brain.

Authors:  Aliya L Frederick; Gregg D Stanwood
Journal:  Dev Neurosci       Date:  2009-04-17       Impact factor: 2.984

3.  Expression and function of dopamine receptors in the developing medial frontal cortex and striatum of the rat.

Authors:  S E Sillivan; C Konradi
Journal:  Neuroscience       Date:  2011-10-08       Impact factor: 3.590

4.  A transgenic mouse model of neuroepithelial cell specific inducible overexpression of dopamine D1-receptor.

Authors:  K Fujimoto; K Araki; D M McCarthy; J R Sims; J Q Ren; X Zhang; P G Bhide
Journal:  Neuroscience       Date:  2010-07-29       Impact factor: 3.590

5.  Thalamocortical functional connectivity and behavioral disruptions in neonates with prenatal cocaine exposure.

Authors:  Andrew P Salzwedel; Karen M Grewen; Barbara D Goldman; Wei Gao
Journal:  Neurotoxicol Teratol       Date:  2016-05-27       Impact factor: 3.763

6.  Prenatal drug exposure affects neonatal brain functional connectivity.

Authors:  Andrew P Salzwedel; Karen M Grewen; Clement Vachet; Guido Gerig; Weili Lin; Wei Gao
Journal:  J Neurosci       Date:  2015-04-08       Impact factor: 6.167

7.  Neonatal +-methamphetamine exposure in rats alters adult locomotor responses to dopamine D1 and D2 agonists and to a glutamate NMDA receptor antagonist, but not to serotonin agonists.

Authors:  Devon L Graham; Robyn M Amos-Kroohs; Amanda A Braun; Curtis E Grace; Tori L Schaefer; Matthew R Skelton; Michael T Williams; Charles V Vorhees
Journal:  Int J Neuropsychopharmacol       Date:  2012-03-06       Impact factor: 5.176

8.  Prenatal cocaine effects on brain structure in early infancy.

Authors:  Karen Grewen; Margaret Burchinal; Clement Vachet; Sylvain Gouttard; John H Gilmore; Weili Lin; Josephine Johns; Mala Elam; Guido Gerig
Journal:  Neuroimage       Date:  2014-07-03       Impact factor: 6.556

Review 9.  Prenatal exposure to drugs: effects on brain development and implications for policy and education.

Authors:  Barbara L Thompson; Pat Levitt; Gregg D Stanwood
Journal:  Nat Rev Neurosci       Date:  2009-03-11       Impact factor: 34.870

Review 10.  Pleiotropic effects of neurotransmission during development: modulators of modularity.

Authors:  Barbara L Thompson; Gregg D Stanwood
Journal:  J Autism Dev Disord       Date:  2008-07-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.